Literature DB >> 15306180

Platelet membrane collagen receptor glycoprotein VI polymorphism is associated with coronary thrombosis and fatal myocardial infarction in middle-aged men.

Elina Ollikainen1, Jussi Mikkelsson, Markus Perola, Antti Penttilä, Pekka J Karhunen.   

Abstract

Glycoprotein VI is a platelet collagen receptor binding to subendothelial collagen after a rupture of an atherosclerotic plaque. The GPVI gene is polymorphic with several SNPs and the T13254C polymorphism predicting amino acid substitution (serine to proline) has been associated with the risk of MI in a preliminary study. We studied the association of the GPVI T13254C with fatal myocardial infarction (MI) and coronary artery disease among the 300 men of the Helsinki Sudden Death Study (HSDS). Genotype frequencies were 77.9% for TT, 20.7% for CT and 1.4% for CC. We found a significant association (P = 0.02) between the C-allele carriers (CT or CC) and coronary thrombosis (OR 2.5, 95% CI: 1.05-6.2). There was also a tendency (P = 0.07) for an association between the C-allele and acute myocardial infarction (AMI) (OR 2.2). The average area of complicated coronary lesions was also significantly (P = 0.01) larger in carriers compared to non-carriers of the C-allele. Our findings support previous results on the role of this GPVI polymorphism, or another linked polymorphism, as a possible predictor of the risk of coronary thrombosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15306180     DOI: 10.1016/j.atherosclerosis.2004.03.021

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  10 in total

Review 1.  Genetically Determined Platelet Reactivity and Related Clinical Implications.

Authors:  Teresa Strisciuglio; Giuseppe Di Gioia; Chiara De Biase; Massimiliano Esposito; Danilo Franco; Bruno Trimarco; Emanuele Barbato
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-05-19

Review 2.  Impact of genetic polymorphisms on platelet function and response to anti platelet drugs.

Authors:  Teresa Strisciuglio; Danilo Franco; Giuseppe Di Gioia; Chiara De Biase; Carmine Morisco; Bruno Trimarco; Emanuele Barbato
Journal:  Cardiovasc Diagn Ther       Date:  2018-10

3.  Polymorphisms in the platelet-specific collagen receptor GP6 are associated with risk of nonfatal myocardial infarction in Caucasians.

Authors:  J R Shaffer; C M Kammerer; J Dorn; R E Ferrell; L Iacoviello; M Trevisan; R P Donahue
Journal:  Nutr Metab Cardiovasc Dis       Date:  2010-03-15       Impact factor: 4.222

4.  Effect of genetic variations in platelet glycoproteins Ibalpha and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy.

Authors:  Paul F Bray; Timothy D Howard; Eric Vittinghoff; David C Sane; David M Herrington
Journal:  Blood       Date:  2006-11-14       Impact factor: 22.113

5.  Polymorphism in the protease-activated receptor-4 gene region associates with platelet activation and perioperative myocardial injury.

Authors:  Jochen D Muehlschlegel; Tjörvi E Perry; Kuang-Yu Liu; Amanda A Fox; Shane A Smith; Peter Lichtner; Charles D Collard; Stanton K Shernan; John H Hartwig; Simon C Body; Karin M Hoffmeister
Journal:  Am J Hematol       Date:  2012-01-07       Impact factor: 10.047

6.  The novel NOX inhibitor 2-acetylphenothiazine impairs collagen-dependent thrombus formation in a GPVI-dependent manner.

Authors:  D Vara; M Campanella; G Pula
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

7.  Genomics: risk and outcomes in cardiac surgery.

Authors:  Tjorvi E Perry; Jochen D Muehlschlegel; Simon C Body
Journal:  Anesthesiol Clin       Date:  2008-09

8.  The low-frequency isoform of platelet glycoprotein VIb attenuates ligand-mediated signal transduction but not receptor expression or ligand binding.

Authors:  Elisabetta Trifiro; Shirley A Williams; Yann Cheli; Kenichi Furihata; Fabio M Pulcinelli; Diane J Nugent; Thomas J Kunicki
Journal:  Blood       Date:  2009-05-22       Impact factor: 22.113

9.  Genetic polymorphisms in platelet-related proteins and coronary artery disease: investigation of candidate genes, including N-acetylgalactosaminyltransferase 4 (GALNT4) and sulphotransferase 1A1/2 (SULT1A1/2).

Authors:  A M O'Halloran; C C Patterson; P Horan; A Maree; R Curtin; A Stanton; P P McKeown; D C Shields
Journal:  J Thromb Thrombolysis       Date:  2008-02-08       Impact factor: 2.300

Review 10.  Molecular Drivers of Platelet Activation: Unraveling Novel Targets for Anti-Thrombotic and Anti-Thrombo-Inflammatory Therapy.

Authors:  Madhumita Chatterjee; Agnes Ehrenberg; Laura Mara Toska; Lisa Maria Metz; Meike Klier; Irena Krueger; Friedrich Reusswig; Margitta Elvers
Journal:  Int J Mol Sci       Date:  2020-10-24       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.